While GLP-1s had mostly been prescribed for patients with type 2 diabetes as recently as two years ago (as of May 2024), the number of patients without a diabetes diagnosis using GLP-1s for weight loss has risen exponentially for example, they grew from 21K in 2019 to 174K in 2023, an increase of more than 700%
Generally, newer medications, such as GLP-1 agonists, are the least likely to be covered, while older drugs are commonly found on formularies
Yes, lean mass loss is real
As potential inducer of HEP expression, phytoestrogens are promising dietary supplements to reduce iron overload and prevent any sequelae of iron-induced toxicities such as hyperferritinemia, coagulopathies and/or thromboembolism, which are prominent clinical manifestations in COVID-19 and PASC 94,144,494,495